Most Popular According To Cardiologists in Circulation, AHA, European Heart Journal and Medscape Medical News | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« One Possible Strategy for an Acquisition is via a Special Purpose Acquisition Company (SPAC)

A Platform called VirtualFlow: Discovery of Pan-coronavirus Drugs help prepare the US for the Next Coronavirus Pandemic »

Most Popular According To Cardiologists in Circulation, AHA, European Heart Journal and Medscape Medical News

January 31, 2021 by 2012pharmaceutical

Most Popular According To Cardiologists in Circulation, AHA, European Heart Journal and Medscape Medical News

Reporter: Aviva Lev-Ari, PhD, RN

Most Popular According To Cardiologists

Saturated Fats and CVD: AHA Convicts, We Say Acquit
Independent Nurse Practitioners and Physician Assistants: A Doc’s View from Medscape
The Case Against Thrombolytic Therapy in Stroke from theheart.org on Medscape
PURE Shakes Up Nutritional Field: Finds High Fat Intake Beneficial from Medscape Medical News
New ACC/AHA Hypertension Guidelines Make 130 the New 140 from Medscape Medical News
Coconut Oil and Heart Health: Fact or Fiction? from Circulation
The Remarkable Story of a Wonder Drug, Which Now Comes to an End in the Primary Prevention Setting: Say Bye-bye to Aspirin! from European Heart Journal
Will the Coronavirus Pandemic Trim the Nonsense in U.S. Healthcare? from Medscape
Plant-Based Diets as Medicine: Food for Thought from theheart.org on Medscape

SOURCE

https://www.medscape.com/mostpopular/specialty/cardiology/mostemailed

Posted in Frontiers in Cardiology and Cardiovascular Disorders | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
- Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation October 4, 2022
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: